Cite
HARVARD Citation
Scheibe, F. et al. (2022). Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology. European journal of neurology. pp. 1847-1854. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Scheibe, F. et al. (2022). Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology. European journal of neurology. pp. 1847-1854. [Online].